Cargando…

Treatment of systemic sclerosis: potential role for stem cell transplantation

Hematopoietic stem cell transplantation may “reset” the immune reconstitution and induce self tolerance of autoreactive lymphocytes, and has been explored in the treatments for systemic sclerosis. Phase I/II trials have shown a satisfactory risk benefit ratio. The true benefit will be identified by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Wen, Derk, Chris T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781687/ https://www.ncbi.nlm.nih.gov/pubmed/24198505

Ejemplares similares

Gastric Antral Vascular Ectasia in Systemic Sclerosis
por: Johnson, Jill, et al.
Publicado: (2011)

Systemic Sclerosis: Current State and Survival After Lung Transplantation
por: Minalyan, Artem, et al.
Publicado: (2021)

The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantation
por: Servaas, N. H., et al.
Publicado: (2020)

Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2018)

Life after Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis
por: Moraes, Daniela A, et al.
Publicado: (2021)

Haematopoietic stem cell transplantation in systemic sclerosis
por: Walker, Ulrich A, et al.
Publicado: (2018)

Role of Stem-Cell Transplantation in Leukemia Treatment
por: Dessie, Gashaw, et al.
Publicado: (2020)

Autologous Haematopoietic Stem Cell Transplantation and Systemic Sclerosis: Focus on Interstitial Lung Disease
por: Bagnato, Gianluca, et al.
Publicado: (2022)

Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis
por: Lycke, Jan, et al.
Publicado: (2020)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis
por: Mohammadi, Reihane, et al.
Publicado: (2021)

Clinically Symptomatic Pericardial Effusions in Hospitalized Systemic Sclerosis Patients: Demographics and Management
por: Hosoya, Hitomi, et al.
Publicado: (2018)

Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches
por: Xue, Elisabetta, et al.
Publicado: (2022)

Advances in the use of stem cell transplants in the treatment of multiple sclerosis
por: Thomas, Rachel, et al.
Publicado: (2022)

Guidelines of the Brazilian society of bone Marrow transplantation on hematopoietic stem cell transplantation as a treatment for the autoimmune diseases systemic sclerosis and multiple sclerosis
por: Rodrigues, Maria Carolina de Oliveira, et al.
Publicado: (2013)

Feasibility and toxicity of hematopoietic stem cell transplant in multiple sclerosis
por: Kuan, Thomas Low Tat, et al.
Publicado: (2017)

Adipose‐Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial
por: Khanna, Dinesh, et al.
Publicado: (2022)

Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?
por: Bakhuraysah, Maha M., et al.
Publicado: (2016)

Hematopoietic Cell Transplantation for Systemic Sclerosis—A Review
por: Levin, Daniel, et al.
Publicado: (2022)

Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis
por: Rosa, Irene, et al.
Publicado: (2021)

A review of hematopoietic stem cell transplantation for autoimmune diseases: multiple sclerosis, systemic sclerosis and Crohn's disease. Position paper of the Brazilian Society of Bone Marrow Transplantation
por: Oliveira, Maria Carolina, et al.
Publicado: (2021)

Progress in germline stem cell transplantation in mammals and the potential usage
por: Zhang, Wen, et al.
Publicado: (2022)

Haematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis: Recent Advances
por: Mariottini, Alice, et al.
Publicado: (2023)

Pericardial effusions and cardiac tamponade in hospitalized systemic sclerosis patients: analysis of the national inpatient sample
por: Basyal, Bikash, et al.
Publicado: (2023)

A prospective, open-label, non-comparative study of ambrisentan with anti-fibrotic agent combination therapy in the treatment of diffuse systemic sclerosis
por: Schorpion, Annemarie, et al.
Publicado: (2018)

The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation
por: Kim, Eun-Jung, et al.
Publicado: (2013)

Combined meta-analysis of systemic effects of allogeneic stem cell transplantation and systemic sclerosis
por: Grigoryev, Dmitry N, et al.
Publicado: (2014)

Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis
por: Kawashima-Vasconcelos, Marianna Y., et al.
Publicado: (2022)

The role of B cells in systemic sclerosis
por: Kraaij, Marina D, et al.
Publicado: (2008)

Spotlight on tocilizumab and its potential in the treatment of systemic sclerosis
por: Sakkas, Lazaros I
Publicado: (2016)

Mesenchymal stem cells in systemic sclerosis therapy
por: Dudek, Daniel Witold, et al.
Publicado: (2020)

Autologous Mesenchymal Stem Cell Transplantation in Multiple Sclerosis: A Meta-Analysis
por: Zhou, Yang, et al.
Publicado: (2019)

Limbal Stem Cell Deficiency and Treatment with Stem Cell Transplantation
por: Barut Selver, Özlem, et al.
Publicado: (2017)

Role of Stem Cell Transplantation in Multiple Myeloma
por: Devarakonda, Srinivas, et al.
Publicado: (2021)

The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis
por: Willison, A. G., et al.
Publicado: (2022)

Is there still a role for cyclophosphamide in the treatment of systemic sclerosis?
por: Vonk, Madelon C
Publicado: (2020)

The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease
por: Zhao, Lu, et al.
Publicado: (2019)

The Roles of γδ T Cells in Hematopoietic Stem Cell Transplantation
por: Ye, Wanyi, et al.
Publicado: (2020)

The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting
por: Metafuni, Elisabetta, et al.
Publicado: (2023)

Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis
por: Gressenberger, Paul, et al.
Publicado: (2021)

Potential Therapeutic Mechanisms and Tracking of Transplanted Stem Cells: Implications for Stroke Treatment
por: Zhang, Yanhong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_83uugbauh2hpfrk34pgjon5kmr